‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.
WHO puts ‘temporary pause’ on hydroxychloroquine trial for coronavirus patients
A trial of hydroxychloroquine for COVID-19 treatment has been suspended after researchers found patients receiving the drug were at higher risk of heart problems and death.
Preparing to vaccinate children under 12 against COVID-19
On 5 December, the Therapeutic Goods Administration (TGA) provisionally approved Pfizer’s COVID-19 vaccine for children over 5 years of age.
Bridging NIPVIP knowledge gaps
For those who were unable to make it to the PSA’s jam-packed NIPVIP webinar, here’s the most sought-after information from the expert hosts.
A day in the life of a general practice pharmacist
Discussing patient outcomes with doctors, visiting patients in their own homes, and co-developing new programs for a General Practice. If that sounds interesting to...
Better COVID-19 communication needed, PSA tells Vic govt committee
Insufficient or unhelpful communication from authorities has been the most frustrating aspect of the COVID-19 crisis since restrictions started, according to Victorian pharmacists.
